NCT01171404

Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge

Long-term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 10,568 (actual)
• Sponsor: AstraZeneca · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this international study is to describe the short- and long-term (i.e. up to 2 years following the index event) antithrombotic management patterns (AMPs) in patients hospitalized for acute coronary syndromes (ST segment elevation myocardial infarction (STEMI), Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS)), and to document the impact of AMPs in clinical outcomes, economic variables and quality of life in a 'real-life' setting and to compare these between sites, countries and regions.

Conditions

• ACS
• Acute Coronary Syndrome
• Myocardial Infarction
• Unstable Angina
• Coronary Artery Disease

Timeline

• Start date: 2010-09-01
• Primary completion: 2013-03-01
• Completion: 2013-03-01
• First posted: 2010-07-28
• Last updated: 2013-04-17

Locations

410 sites across 20 countries: Argentina, Belgium, Brazil, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Mexico, Netherlands, Norway, Poland, Romania, Slovenia, Spain, Turkey (Türkiye), United Kingdom, Venezuela